Estimated percentage time in work activities
| . | Mean (SD) . | Median . | IQR* . | Range . |
|---|---|---|---|---|
| Percentage of overall time | ||||
| Clinical practice | 61.0 (25.5) | 65 | 40, 85 | 0-100 |
| Research | 23.7 (24.4) | 12.5 | 4, 40 | 0-100 |
| Education | 5.2 (7.7) | 2 | 0, 10 | 0-40 |
| Administration | 9.3 (12.2) | 5 | 0, 15 | 0-60 |
| Other | 1.0 (7.0) | 0 | 0, 0 | 0-60 |
| Percentage of clinical time | ||||
| Solid tumors | 52.1 (40.7) | 60 | 0, 100 | 0-100 |
| Hematologic malignancies | 37.5 (40.1) | 20 | 0, 90 | 0-100 |
| Nonmalignant hematologic disorders | 10.0 (15.0) | 5 | 0, 15 | 0-95 |
| Transfusion medicine | 0.5 (1.6) | 0 | 0, 0 | 0-10 |
| . | Mean (SD) . | Median . | IQR* . | Range . |
|---|---|---|---|---|
| Percentage of overall time | ||||
| Clinical practice | 61.0 (25.5) | 65 | 40, 85 | 0-100 |
| Research | 23.7 (24.4) | 12.5 | 4, 40 | 0-100 |
| Education | 5.2 (7.7) | 2 | 0, 10 | 0-40 |
| Administration | 9.3 (12.2) | 5 | 0, 15 | 0-60 |
| Other | 1.0 (7.0) | 0 | 0, 0 | 0-60 |
| Percentage of clinical time | ||||
| Solid tumors | 52.1 (40.7) | 60 | 0, 100 | 0-100 |
| Hematologic malignancies | 37.5 (40.1) | 20 | 0, 90 | 0-100 |
| Nonmalignant hematologic disorders | 10.0 (15.0) | 5 | 0, 15 | 0-95 |
| Transfusion medicine | 0.5 (1.6) | 0 | 0, 0 | 0-10 |
Quartile 1, quartile 3.